Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JonesTrading Upgrades Deciphera Pharmaceuticals to Hold

JonesTrading Upgrades Deciphera Pharmaceuticals to Hold

JonesTrading analyst Soumit Roy upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Sell to Hold.

byBenzinga Newsdesk

January 6, 2023

1 minute read

JonesTrading analyst Soumit Roy upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Sell to Hold.

Analyst Ratings

Analyst Expectations for SeaWorld Entertainment’s Future

By Benzinga Insights

August 21, 12:00 PM

Within the last quarter, SeaWorld Entertainment (NYSE:SEAS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

SEAS

Analyst Ratings

What 8 Analyst Ratings Have To Say About Essex Property Trust

By Benzinga Insights

September 8, 9:00 AM

Over the past 3 months, 8 analysts have published their opinion on Essex Property Trust (NYSE:ESS) stock. These…

ESS

News

CNBC’s David Faber Comment, Twitter Shares Pare Gains, Last Up 2.75% At $43.92 After CNBC Reports Serious Settlement Talks Between Company And Musk Not Seen Underway

By Benzinga Newsdesk

September 30, 1:57 PM

- CNBC

TWTR

Brittney Griner’s Former College Coach Refuses To Comment On Her Russia Detention, Twitter Blows Up

By Maureen Meehan

September 26, 10:57 PM

Louisiana State University (LSU) women’s basketball coach Kim Mulkey was asked to comment on Brittney Griner's detention in Russia, to which she abruptly declined.